(Q35129917)

6 August 2017

0 references

1 reference

title

Interferon alpha in the treatment of chronic hepatitis C in children: a meta-analysis [correction of metanalysis]. (English)

1 reference

6 August 2017

1 reference

1 reference

V Di Ciommo

1

1 reference

6 August 2017

P Russo

series ordinal

2

1 reference

6 August 2017

L Ravà

series ordinal

3

1 reference

6 August 2017

L Caprino

series ordinal

4

1 reference

6 August 2017

publication date

1 May 2003

1 reference

Journal of Viral Hepatitis

6 August 2017

published in

1 reference

6 August 2017

volume

10

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

210-214

1 reference

Chronic hepatitis C and interferon alpha: conventional and cumulative meta-analyses of randomized controlled trials

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00420.X

Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00420.X

Cost effectiveness analysis of different strategies of management of chronic hepatitis C infection in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00420.X

Interferon-alpha therapy for chronic hepatitis B in children: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00420.X

An analysis of published trials of interferon monotherapy in children with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00420.X

Chronic hepatitis C viral infection in childhood: to treat or not to treat with interferon--that is the question

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00420.X

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00420.X

High dosage alpha-interferon for treatment of children and young adults with chronic hepatitis C disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00420.X

Interferon-alpha-2b treatment of chronic hepatitis C in children with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00420.X

Efficacy of interferons in treating children with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00420.X

Interferon-alpha treatment of chronic hepatitis C virus infection in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00420.X

Low virological response to interferon in children with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00420.X

Favorable response to lymphoblastoid interferon-alpha in children with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00420.X

Response to interferon alfa-2b therapy in mutitransfused children with beta-thalassemia and chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00420.X

Sustained response to interferon-alpha2a monotherapy of young blood donors with minimal-to-mild chronic hepatitis C. The Donor Surveillance Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00420.X

Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00420.X

Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00420.X

Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2003.00420.X

10.1046/J.1365-2893.2003.00420.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference